Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients
Open Access
- 1 July 2012
- journal article
- research article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 18 (7), 680-687
- https://doi.org/10.1111/j.1469-0691.2012.03784.x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for ChemotherapyMycoses, 2011
- Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in intensive care unit study*Critical Care Medicine, 2011
- Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 PatientsAntimicrobial Agents and Chemotherapy, 2011
- European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 UpdateBone Marrow Transplantation, 2010
- Invasive Fungal Infections in the Intensive Care UnitSeminars in Respiratory and Critical Care Medicine, 2010
- Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005–2006)Critical Care Medicine, 2009
- Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. TreatmentIntensive Care Medicine, 2008
- Epidemiology of Invasive Candidiasis: a Persistent Public Health ProblemClinical Microbiology Reviews, 2007
- In Vitro Activities of Anidulafungin against More than 2,500 Clinical Isolates of Candida spp., Including 315 Isolates Resistant to FluconazoleJournal of Clinical Microbiology, 2005